Back to search
Hereditary Coproporphyria (HCP)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hereditary Coproporphyria (HCP) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hereditary Coproporphyria (HCP) trials you may qualify forThis global patient registry is being conducted to characterize the natural history and real-world clinical management of patients with AHP, and to further char…
The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pr…
The purpose of this study is to determine if Panhematin is safe and effective for prevention of acute attacks of porphyria. The study aims to provide high qual…
To determine the proportion of patients suffering from acute hepatic porphyria (AHP) from different hospital departments and referred to an internist referent f…
Postural Tachycardia Syndrome (POTS) is the most common autonomic disorder and is estimated to affect 3,000,000 individuals in the United States, with 80-85% of…